Our analysis revealed that ZNF506-targeted ERVPs were significantly down-regulated in AML-leukemic blast cells, consistent with the overall trend of repeat element expression in these cells (Figure 6B; Supplementary Figure S12d) (54). Here, ZNF506 is linked to acute myeloid leukemia.